Application no. and date | 00969304.5 (espacenet) (Federated) (European Patent Register), 20000926 | Patent/reg. no. and date | DK/EP 1216047, 20051012 | Publication date | 20020626 | Priority no. and date | DE 19947235, 19990930 | EP pub. no. and date |
EP 1216047 20020626 | Effective date | | Applicant/owner | MEDA Pharma GmbH & Co. KG, Benzstrasse 1
61352 Bad Homburg, DE | Applicant ref. no. | 81320 | Inventor | SZELENYI, Istvan, Händelstrasse 32
90571 Schwaig, DE, HEER, Sabine, Lindenauer Strasse 13
01445 Radebeul, DE, ENGEL, Jürgen, Erlenweg 3
63755 Alzenau, DE, POPPE, Hildegard, Kieler Strasse 6
01109 Dresden, DE | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/135 (2006.01) , A61K 31/165 (2006.01) , A61K 31/167 (2006.01) , A61K 31/522 (2006.01) , A61K 31/56 (2006.01) , A61K 31/57 (2006.01) , A61K 9/12 (2006.01) , A61P 11/00 (2006.01) , A61P 11/06 (2006.01) | Title | Kombination af loteprednol og beta-2-adrenoreceptoragonister og dens anvendelse ved inhalation til behandling af bronkial astma | Int. application no. | EP2000009392 | Int. publication no. | WO2001022956 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|